Success Stories: EB-1A Approved for Postdoctoral Fellow in New Jersey in the Field of Mitochondrial Disorders

 

Client’s Testimonial:

 

Thank you so much. I also got an email of the approved notice. This is really a great news. Hats off you guys. I already telling people and soon they are going to send you their CV for the evaluation.

 


On April 23rd, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Postdoctoral Fellow in the Field of Mitochondrial Disorders (Approval Notice)


General Field: Mitochondrial Disorders

Position at the Time of Case Filing: Postdoctoral Fellow

Country of Origin: India

Service Center: Texas Service Center (TSC)

State of Residence at the Time of Filing: New Jersey

Approval Notice Date: April 23rd, 2015

Processing Time: 1 month, 7 days (15 days after Premium Processing was requested)

 

 


Case Summary:

In this case, the client that we had the opportunity to work with was a Postdoctoral Fellow from India in the field of Mitochondrial Disorders.  His work had resulted in 34 peer-reviewed scientific articles and numerous presentations at national and international conferences; at the time that his case was filed, his publications had been cited at least 723 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work.  He had also reviewed 30 manuscripts for distinctive, internationally-circulated journals.  His superior level of expertise was confirmed in the following quote from an independent recommender, He has done some outstanding work that already has been shown to have an impact on clinical treatment. I do not hesitate to say that he is a leader in his field of study and should absolutely be allowed every opportunity to progress further.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Mitochondrial Disorders, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 1 month and 7 days.